NR0B1 and cervical cancer: In cervical cancer, silencing DAX1 can significantly inhibit the proliferation of cancer cells in vitro, the properties of cancer stem cells and the tumorigenic ability in vivo, and this effect has also been shown to be related to the inhibition of Wnt/β-catenin pathway activation [45].